Clinical Trial Update: Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ropinirole hydrochloride in Unverricht-Lundborg syndrome (progressive myoclonic epilepsy).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unverricht-lundborg Syndrome

Drugs mentioned

• Ropinirole hydrochloride (ropinirole hydrochloride)

Snippet

Sponsor: University of Turku | Conditions: Unverricht-Lundborg Syndrome | Phase 2 | Status: UNKNOWN